Yuanli Chemical GroupLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Yuanli Chemical GroupLtd heeft een totaal eigen vermogen van CN¥3.2B en een totale schuld van CN¥310.0M, wat de schuld-eigenvermogensverhouding op 9.6% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥4.0B en CN¥752.1M. De EBIT Yuanli Chemical GroupLtd is CN¥196.2M waardoor de rentedekking -4.6 is. Het heeft contanten en kortetermijnbeleggingen van CN¥1.5B.

Belangrijke informatie

9.6%

Verhouding schuld/eigen vermogen

CN¥310.00m

Schuld

Rente dekkingsratio	-4.6x
Contant	CN¥1.51b
Aandelen	CN¥3.23b
Totaal verplichtingen	CN¥752.06m
Totaal activa	CN¥3.98b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Yuanli Chemical Group Co.,Ltd. (SHSE:603217) Held Back By Insufficient Growth Even After Shares Climb 25%

Nov 12

Yuanli Chemical GroupLtd's (SHSE:603217) Problems Go Beyond Weak Profit

Nov 05

Yuanli Chemical GroupLtd (SHSE:603217) Will Want To Turn Around Its Return Trends

Oct 23

Take Care Before Diving Into The Deep End On Yuanli Chemical Group Co.,Ltd. (SHSE:603217)

Sep 28

Yuanli Chemical GroupLtd's (SHSE:603217) Shareholders Have More To Worry About Than Only Soft Earnings

Apr 23

Yuanli Chemical Group Co.,Ltd.'s (SHSE:603217) Shares Bounce 26% But Its Business Still Trails The Market

Mar 07

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥2.4B ) 603217 } overtreffen de korte termijn passiva ( CN¥718.4M ).

Langlopende schulden: De kortetermijnactiva 603217 ( CN¥2.4B ) overtreffen de langetermijnschulden ( CN¥33.7M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 603217 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 603217 is de afgelopen 5 jaar gestegen van 0.1% naar 9.6%.

Schuldendekking: De operationele kasstroom van 603217 is negatief, waardoor de schuld niet goed gedekt is.

Rentedekking: 603217 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Yuanli Chemical GroupLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Yuanli Chemical Group Co.,Ltd. (SHSE:603217) Held Back By Insufficient Growth Even After Shares Climb 25%

Yuanli Chemical GroupLtd's (SHSE:603217) Problems Go Beyond Weak Profit

Third quarter 2024 earnings released: EPS: CN¥0.25 (vs CN¥0.27 in 3Q 2023)

Investor sentiment improves as stock rises 17%

Yuanli Chemical GroupLtd (SHSE:603217) Will Want To Turn Around Its Return Trends

Yuanli Chemical Group Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 23%

Take Care Before Diving Into The Deep End On Yuanli Chemical Group Co.,Ltd. (SHSE:603217)

Second quarter 2024 earnings released: EPS: CN¥0.24 (vs CN¥0.30 in 2Q 2023)

Yuanli Chemical Group Co.,Ltd. to Report First Half, 2024 Results on Aug 28, 2024

First quarter 2024 earnings released: EPS: CN¥0.27 (vs CN¥0.31 in 1Q 2023)

Yuanli Chemical GroupLtd's (SHSE:603217) Shareholders Have More To Worry About Than Only Soft Earnings

Full year 2023 earnings: EPS and revenues miss analyst expectations

Yuanli Chemical Group Co.,Ltd., Annual General Meeting, May 08, 2024

Yuanli Chemical Group Co.,Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Yuanli Chemical Group Co.,Ltd.'s (SHSE:603217) Shares Bounce 26% But Its Business Still Trails The Market

Yuanli Chemical Group Co.,Ltd. (SHSE:603217) announces an Equity Buyback for CNY 92 million worth of its shares.

Investor sentiment deteriorates as stock falls 23%

New minor risk - Share price stability

Investor sentiment improves as stock rises 21%

Yuanli Chemical Group Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 17, 2024

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: CN¥0.30 (vs CN¥0.80 in 2Q 2022)

Yuanli Chemical Group Co.,Ltd. to Report First Half, 2023 Results on Aug 28, 2023

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.47 (vs CN¥0.49 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.80 (vs CN¥0.46 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: CN¥1.03 (vs CN¥0.64 in 1Q 2021)

No independent directors

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.78 (vs CN¥0.33 in 3Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS CN¥0.73 (vs CN¥0.33 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥1.24 (vs CN¥1.22 in FY 2019)

New 90-day low: CN¥23.45

Yuanli Chemical Group Co.,Ltd. (SHSE:603217) agreed to acquire 10% stake in Chongqing Zesheng Shipping Affairs (Group) Co., Ltd from Chongqing Zesheng Investment Group Co., Ltd for RMB 80 million.

New 90-day low: CN¥23.92

New 90-day low: CN¥26.08

Third quarter earnings released

First half earnings released

New 90-day high - CN¥31.30

Yuanli Chemical Group Co.,Ltd. to Report First Half, 2020 Results on Aug 25, 2020

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven